ARTHEx Biotech raised $87M in a Series B round to advance its ATX-01 program for Myotonic Dystrophy Type 1 and expand its pipeline of targeted RNA medicines.
Amount Raised
$87 Million
Round Type
Series B
Investors
Description
ARTHEx Biotech has successfully upsized its Series B financing round to $87 million. The funds will be used to advance the lead program ATX-01 focused on Myotonic Dystrophy Type 1. Additionally, the company aims to expand its pipeline of targeted RNA medicines. This funding will help propel their innovative research and development initiatives.
Quick answer
ARTHEx Biotech raised $87 Million in a Series B round, dated September 17, 2025. Investors: Sound Bioventures, Invivo Partners, Hadean Ventures, European Innovation Council, Columbus Venture Partners, Cdti Innovación, AdBio Partners and Bpifrance.
- How much did ARTHEx Biotech raise?
- ARTHEx Biotech raised $87 Million in a Series B round on September 17, 2025.
- Who invested in ARTHEx Biotech?
- Sound Bioventures, Invivo Partners, Hadean Ventures, European Innovation Council, Columbus Venture Partners, Cdti Innovación, AdBio Partners and Bpifrance are named as investors in this round.
- What does ARTHEx Biotech do?
- ARTHEx Biotech is a spin-off biotech company from the University of Valencia (Spain) focused on the research and development of novel oligonucleotide therapies that modulate microRNA to treat diseases with unmet medical..
- Where is ARTHEx Biotech based and how big is it?
- Fundz records about 2 employees.
- Who are the decision-makers at ARTHEx Biotech?
- Fundz holds 1 contact at ARTHEx Biotech. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ARTHEx Biotech that raised within 45 days of this round, from Fundz verified event records.
- Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
- CoRegen raised $14M on October 28, 2025.
- Hemab Therapeutics raised $157M (Series C) on October 27, 2025.
- Acasti raised $4M (Funding Round) on October 23, 2025.
- ENA Respiratory raised $22M (Series B) on October 22, 2025.
- Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
Who to call at ARTHEx Biotech, and when
A new round usually means ARTHEx Biotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ARTHEx Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARTHEx Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARTHEx Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARTHEx Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansARTHEx Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.